6 min read Fertility Education

The NAD+ Wellness Boom: Why Younger Consumers Are Investing in Health Earlier

NAD+ supplements are moving beyond anti-aging and into beauty, recovery, and general wellness, especially among younger consumers. Here is what is driving that shift and why interest is growing faster than clinical certainty.

The NAD+ Wellness Boom: Why Younger Consumers Are Investing in Health Earlier

Why NAD+ Is Suddenly Everywhere

NAD+ supplements are no longer being marketed only as tools for older adults worried about aging. They are increasingly being positioned as part of a much broader wellness identity, one that includes recovery, beauty, energy, and sometimes even fertility. That shift helps explain why the NAD+ category is attracting younger buyers who are thinking less about reversing visible decline and more about investing early in long-term health.

Glossy’s November 13, 2025 report on Tru Niagen’s beauty launch and the younger NAD+ consumer says the company’s fastest-growing demographic is now people in their 30s, not the over-60 audience it first built around. The same article describes a broader repositioning of NAD+ from a longevity niche into a more mainstream wellness category shaped by recovery, skin health, and preventative self-care.

The NAD+ Wellness Boom: Why Younger Consumers Are Investing in Health Earlier

What Is Driving the Shift?

Why are younger people buying in now?

The same Glossy article on NAD+ supplement demand among younger wellness consumers quotes Tru Niagen’s leadership saying the category has moved “much, much younger” in just the last few years. The article specifically points to highly educated consumers in their 30s, women trying to conceive, professional athletes, and frequent exercisers as rapidly growing groups.

That trend reflects a larger change in the wellness market. Many younger consumers are not waiting for obvious symptoms of aging before spending money on health-related products. They are approaching wellness more proactively, often looking for products they believe can support energy, recovery, appearance, and long-term resilience all at once.

Why Beauty and Wellness Are Blending Together

What makes NAD+ attractive to beauty-focused brands?

The Glossy report on Tru Niagen Beauty and NAD+’s expansion into beauty supplements says the company’s new beauty product is designed to support skin elasticity, moisture retention, and the appearance and strength of hair and nails while also increasing NAD+ support. That positioning matters because it shows how beauty marketing is increasingly being framed through cellular health rather than only surface-level results.

This kind of product strategy makes wellness feel more approachable to consumers who might not think of themselves as shopping for “longevity supplements.” Instead, they may enter through beauty, skin health, or fitness recovery and only later absorb the broader health messaging attached to the same category.

Where Fertility Fits Into This Story

Why does fertility show up in NAD+ marketing conversations?

The same Glossy article on younger NAD+ consumers and category expansion explicitly mentions women looking to conceive as one of the fast-growing consumer groups in this space. That does not mean NAD+ supplements have become proven fertility treatments. It does mean fertility-aware consumers are increasingly encountering this category in wellness and beauty settings before they ever hear about it in a clinic.

That overlap is exactly where clear education matters. People may reasonably ask whether a product being marketed for cellular health or longevity also has reproductive implications. But consumer interest is not the same thing as clinical evidence. A supplement trend can grow quickly even while the fertility-specific evidence remains limited, early, or more mechanistic than outcome-based.

If you want a more fertility-centered look at what NAD+ is doing biologically, the fertility power duo: how NAD+ and glutathione support egg health and why egg quality matters more than you think—and how to support it naturally help separate basic biology from marketing language.

Why the Distinction Between Trend and Proof Matters

What should patients be careful not to assume?

The Glossy article on the growth of the NAD+ category and new product development describes a market that is expanding quickly, with companies anticipating more research and trying to create easier entry points for younger consumers. That is useful market information, but it is not the same as individualized fertility guidance.

Patients still need help answering different questions: What does the current evidence actually show? Is this product being discussed because of real reproductive data or because it fits broader longevity and wellness narratives? How should someone weigh interest in a supplement against fertility testing, age, ovarian reserve, sperm factors, or a more urgent treatment timeline?

How Her Serenity Frames the NAD+ Trend

At Her Serenity, this topic belongs in our mission because patients are increasingly encountering wellness trends long before they appear in traditional fertility conversations. When a supplement category like NAD+ begins to overlap with beauty, recovery, and fertility, people need clear, grounded information about what is driving that interest and what those products are actually designed to do. That kind of visibility helps patients make more informed decisions instead of relying on marketing language or assuming that a wellness trend automatically translates into proven fertility benefit.

At the same time, consumer interest is not the same as clinical proof. NAD+ support may be a promising area of wellness and longevity research, but trend momentum does not replace individualized fertility evaluation, evidence-based treatment planning, or careful guidance about what is known versus still emerging. Trust means helping patients understand both the appeal and the limits of products like these, so they can weigh potential value thoughtfully and choose next steps that fit their health, goals, and stage of care.

Share this article

Share this article

Back to All Articles